State-of-the-art materials for ultrasound-triggered drug delivery

Advanced Drug Delivery Reviews

Volumn 72, Issue , 2014, Pages 3-14

  Sirsi, Shashank R ^a   Borden, Mark A ^a  

^a University of Colorado   (United States)

Author keywords

Liposomes; Micelles; Microbubbles; Phase change agents; Targeted drug delivery

Indexed keywords

DRUG DELIVERY; LIPOSOMES; MICELLES;

CHEMOTHERAPEUTIC AGENTS; DRUG DEPOSITIONS; MICROBUBBLES; PHASE CHANGES; RATIONAL DESIGN; RECENT PROGRESS; TARGETED DRUG DELIVERY; ULTRASOUND WAVES;

ULTRASONICS;

HYDROGEL;

ANIMAL; DRUG DELIVERY SYSTEM; HYDROGEL; MICROBUBBLE; PROCEDURES; ULTRASOUND;

ANIMALS; DRUG DELIVERY SYSTEMS; HYDROGELS; MICROBUBBLES; ULTRASONICS;

EID: 84901602602     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.12.010     Document Type: Review

References (125)

1. Loverock P., ter Haar G., Ormerod M.G., Imrie P.R. The effect of ultrasound on the cytotoxicity of adriamycin. Br. J. Radiol. 1990, 63:542-546.
2. Bao S., Thrall B.D., Miller D.L. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med. Biol. 1997, 23:953-959.
3. Tachibana K., Uchida T., Tamura K., Eguchi H., Yamashita N., Ogawa K. Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells. Cancer Lett. 2000, 149:189-194.
4. Tachibana K., Uchida T., Ogawa K., Yamashita N., Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet 1999, 353:1409.
5. Saito K., Miyake K., McNeil P.L., Kato K., Yago K., Sugai N. Plasma membrane disruption underlies injury of the corneal endothelium by ultrasound. Exp. Eye Res. 1999, 68:431-437.
6. Domenici F., Giliberti C., Bedini A., Palomba R., Luongo F., Sennato S., et al. Ultrasound well below the intensity threshold of cavitation can promote efficient uptake of small drug model molecules in fibroblast cells. Drug Deliv. 2013, 20:285-295.
7. Rapoport N.Y., Herron J.N., Pitt W.G., Pitina L. Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: effect of micelle structure and ultrasound on the intracellular drug uptake. J. Control. Release Off. J. Control. Release Soc. 1999, 58:153-162.
8. Sirsi S.R., Borden M.A. Advances in ultrasound mediated gene therapy using microbubble contrast agents. Theranostics 2012, 2:1208-1222.
9. Halliwell M. A tutorial on ultrasonic physics and imaging techniques. Proc. Inst. Mech. Eng. H. 2010, 224:127-142.
10. Azhari H. Basics of Biomedical Ultrasound for Engineers 2010, Wiley: IEEE, Hoboken, N.J.
11. Abbott J.G. Rationale and derivation of MI and TI-a review. Ultrasound Med. Biol. 1999, 25:431-441.
12. Dalecki D. Mechanical bioeffects of ultrasound. Annu. Rev. Biomed. Eng. 2004, 6:229-248.
13. Leighton T.G. The Acoustic Bubble 1994, Academic Press, London.
14. Lantheus Medical Imaging How to Use DEFINITY®: System Optimization 2013.
15. Coussios C.C., Roy R.A. Applications of acoustics and cavitation to noninvasive therapy and drug delivery. Annu. Rev. Fluid Mech. 2008, 40:395-420.
16. Miller D.L. Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation. Prog. Biophys. Mol. Biol. 2007, 93:314-330.
17. Miller D.L., Smith N.B., Bailey M.R., Czarnota G.J., Hynynen K., Makin I.R.S., et al. Overview of therapeutic ultrasound applications and safety considerations. J. Ultrasound Med. Off. J. Am. Inst. Ultrasound Med. 2012, 31:623-634.
18. Pitt W.G., Husseini G.A., Staples B.J. Ultrasonic drug delivery-a general review. Expert Opin. Drug Deliv. 2004, 1:37-56.
19. Shankar H., Pagel P.S. Potential Adverse Ultrasound-Related Biological Effects: A Critical Review. Anesthesiology 2011, 115(5):1109-1124. 10.1097/ALN.0b013e31822fd1f1.
20. Qin S., Caskey C.F., Ferrara K.W. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys. Med. Biol. 2009, 54:R27-R57.
21. Postema M., Schmitz G. Bubble dynamics involved in ultrasonic imaging. Expert. Rev. Mol. Diagn. 2006, 6:493-502.
22. Baker K.G., Robertson V.J., Duck F.A. A review of therapeutic ultrasound: biophysical effects. Phys. Ther. 2001, 81:1351-1358.
23. Shi X., Martin R.W., Vaezy S., Crum L.A. Quantitative investigation of acoustic streaming in blood. J. Acoust. Soc. Am. 2002, 111:1110-1121.
24. Dayton P.A., Allen J.S., Ferrara K.W. The magnitude of radiation force on ultrasound contrast agents. J. Acoust. Soc. Am. 2002, 112:2183-2192.
25. Shortencarier M.J., Dayton P.A., Bloch S.H., Schumann P.A., Matsunaga T.O., Ferrara K.W. A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 2004, 51:822-831.
26. Doinikov A.A., Bouakaz A. Acoustic microstreaming around an encapsulated particle. J. Acoust. Soc. Am. 2010, 127:1218-1227.
27. Diederich C.J., Hynynen K. Ultrasound technology for hyperthermia. Ultrasound Med. Biol. 1999, 25:871-887.
28. Diederich C.J. Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation. Int. J. Hyperth. Off. J. Eur. Soc. Hyperthermic Oncol. North Am. Hyperth. Group. 2005, 21:745-753.
29. Quesson B., de Zwart J.A., Moonen C.T. Magnetic resonance temperature imaging for guidance of thermotherapy. J. Magn. Reson. Imaging JMRI. 2000, 12:525-533.
30. Partanen A., Tillander M., Yarmolenko P.S., Wood B.J., Dreher M.R., Kohler M.O. Reduction of peak acoustic pressure and shaping of heated region by use of multifoci sonications in MR-guided high-intensity focused ultrasound mediated mild hyperthermia. Med. Phys. 2013, 40:013301.
31. Kaneko Y., Maruyama T., Takegami K., Watanabe T., Mitsui H., Hanajiri K., et al. Use of a microbubble agent to increase the effects of high intensity focused ultrasound on liver tissue. Eur. Radiol. 2005, 15:1415-1420.
32. Yu T., Wang G., Hu K., Ma P., Bai J., Wang Z. A microbubble agent improves the therapeutic efficiency of high intensity focused ultrasound: a rabbit kidney study. Urol. Res. 2004, 32:14-19.
33. Yu T., Xiong S., Mason T.J., Wang Z. The use of a micro-bubble agent to enhance rabbit liver destruction using high intensity focused ultrasound. Ultrason. Sonochem. 2006, 13:143-149.
34. Lu Y., Park K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int. J. Pharm. 2013, 453:198-214.
35. D'Addio S.M., Prud'homme R.K. Controlling drug nanoparticle formation by rapid precipitation. Adv. Drug Deliv. Rev. 2011, 63:417-426.
36. Husseini G.A., Pitt W.G. The use of ultrasound and micelles in cancer treatment. J. Nanosci. Nanotechnol. 2008, 8:2205-2215.
37. Munshi N., Rapoport N., Pitt W.G. Ultrasonic activated drug delivery from Pluronic P-105 micelles. Cancer Lett. 1997, 118:13-19.
38. Rapoport N. Stabilization and activation of Pluronic micelles for tumor-targeted drug delivery. Colloids Surf. B: Biointerfaces 1999, 16:93-111.
39. Rapoport N. Ultrasound-mediated micellar drug delivery. Int. J. Hyperth. Off. J. Eur. Soc. Hyperthermic Oncol. North Am. Hyperth. Group. 2012, 28:374-385.
40. Husseini G.A., Myrup G.D., Pitt W.G., Christensen D.A., Rapoport N.Y. Factors affecting acoustically triggered release of drugs from polymeric micelles. J. Control. Release Off. J. Control. Release Soc. 2000, 69:43-52.
41. Husseini G.A., Christensen D.A., Rapoport N.Y., Pitt W.G. Ultrasonic release of doxorubicin from Pluronic P105 micelles stabilized with an interpenetrating network of N, N-diethylacrylamide. J. Control. Release Off. J. Control. Release Soc. 2002, 83:303-305.
42. Husseini G.A., Diaz de la Rosa M.A., Richardson E.S., Christensen D.A., Pitt W.G. The role of cavitation in acoustically activated drug delivery. J. Control. Release Off. J. Control. Release Soc. 2005, 107:253-261.
43. Marin A., Sun H., Husseini G.A., Pitt W.G., Christensen D.A., Rapoport N.Y. Drug delivery in pluronic micelles: effect of high-frequency ultrasound on drug release from micelles and intracellular uptake. J. Control. Release Off. J. Control. Release Soc. 2002, 84:39-47.
44. Husseini G.A., Velluto D., Kherbeck L., Pitt W.G., Hubbell J.A., Christensen D.A. Investigating the acoustic release of doxorubicin from targeted micelles. Colloids Surf. B: Biointerfaces 2013, 101:153-155.
45. Mohan P., Rapoport N. Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol. Pharm. 2010, 7:1959-1973.
46. Hasanzadeh H., Mokhtari-Dizaji M., Bathaie S.Z., Hassan Z.M. Effect of local dual frequency sonication on drug distribution from polymeric nanomicelles. Ultrason. Sonochem. 2011, 18:1165-1171.
47. Wang J., Pelletier M., Zhang H., Xia H., Zhao Y. High-frequency ultrasound-responsive block copolymer micelle. Langmuir ACS J. Surf. Colloids. 2009, 25:13201-13205.
48. Pelletier M., Babin J., Tremblay L., Zhao Y. Investigation of a new thermosensitive block copolymer micelle: hydrolysis, disruption, and release. Langmuir 2008, 24:12664-12670.
49. Allen T.M., Cullis P.R. Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev. 2013, 65:36-48.
50. Gabizon A.A. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest. 2001, 19:424-436.
51. Fang J., Nakamura H., Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 2011, 63:136-151.
52. Schroeder A., Kost J., Barenholz Y. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem. Phys. Lipids 2009, 162:1-16.
53. Krasovitski B., Frenkel V., Shoham S., Kimmel E. Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3258-3263.
54. Lin H.Y., Thomas J.L. Factors affecting responsivity of unilamellar liposomes to 20kHz ultrasound. Langmuir ACS J. Surf. Colloids. 2004, 20:6100-6106.
55. Schroeder A., Avnir Y., Weisman S., Najajreh Y., Gabizon A., Talmon Y., et al. Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. Langmuir ACS J. Surf. Colloids. 2007, 23:4019-4025.
56. Somaglino L., Bouchoux G., Mestas J.L., Lafon C. Validation of an acoustic cavitation dose with hydroxyl radical production generated by inertial cavitation in pulsed mode: application to in vitro drug release from liposomes. Ultrason. Sonochem. 2011, 18:577-588.
57. Lafon C., Somaglino L., Bouchoux G., Mari J.M., Chesnais S., Ngo J., et al. Feasibility study of cavitation-induced liposomal doxorubicin release in an AT2 Dunning rat tumor model. J. Drug Target. 2012, 20:691-702.
58. T.J. Evjen, E. Hagtvet, A. Moussatov, S. Røgnvaldsson, J.-L. Mestas, R.A. Fowler, et al., In vivo monitoring of liposomal release in tumours following ultrasound stimulation, Eur. J. Pharm. Biopharm. (n.d.).
59. Weinstein J.N., Magin R.L., Yatvin M.B., Zaharko D.S. Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors. Science 1979, 204:188-191.
60. Tacker J.R., Anderson R.U. Delivery of antitumor drug to bladder cancer by use of phase transition liposomes and hyperthermia. J. Urol. 1982, 127:1211-1214.
61. Needham D., Anyarambhatla G., Kong G., Dewhirst M.W. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res. 2000, 60:1197-1201.
62. Gasselhuber A., Dreher M.R., Rattay F., Wood B.J., Haemmerich D. Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model. PloS One. 2012, 7:e47453.
63. Kong G., Anyarambhatla G., Petros W.P., Braun R.D., Colvin O.M., Needham D., et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 2000, 60:6950-6957.
64. Dromi S., Frenkel V., Luk A., Traughber B., Angstadt M., Bur M., et al. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2007, 13:2722-2727.
65. Paoli E.E., Kruse D.E., Seo J.W., Zhang H., Kheirolomoom A., Watson K.D., et al. An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: importance of formulation. J. Control. Release Off. J. Control. Release Soc. 2010, 143:13-22.
66. Ning S., Macleod K., Abra R.M., Huang A.H., Hahn G.M. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Int. J. Radiat. Oncol. Biol. Phys. 1994, 29:827-834.
67. Oerlemans C., Deckers R., Storm G., Hennink W.E., Nijsen J.F.W. Evidence for a new mechanism behind HIFU-triggered release from liposomes. J. Controlled Release. 2013, 168:327-333.
68. Evjen T.J., Nilssen E.A., Rognvaldsson S., Brandl M., Fossheim S.L. Distearoylphosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery. Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV. 2010, 75:327-333.
69. Lentacker I., De Smedt S.C., Sanders N.N. Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter 2009, 5:2161-2170.
70. Sirsi S., Borden M. Microbubble compositions, properties and biomedical applications. Bubble Sci. Eng. Technol. 2009, 1:3-17.
71. Kabalnov A., Klein D., Pelura T., Schutt E., Weers J. Dissolution of multicomponent microbubbles in the bloodstream: 1. Theory. Ultrasound Med. Biol. 1998, 24:739-749.
72. Tartis M.S., Kruse D.E., Zheng H., Zhang H., Kheirolomoom A., Marik J., et al. Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. J. Control. Release Off. J. Control. Release Soc. 2008, 131:160-166.
73. Crum L. Nucleation and stabilization of microbubbles in liquids. Appl. Sci. Res. 1982, 38:101-115.
74. Wu J., Nyborg W.L. Ultrasound, cavitation bubbles and their interaction with cells. Adv. Drug Deliv. Rev. 2008, 60:1103-1116.
75. Borden M.A., Streeter J.E., Dayton P.A., Sirsi S.R. In vivo demonstration of cancer molecular imaging with ultrasound radiation force and buried-ligand microbubbles. Mol. Imaging 2013, 12:1.
76. Caskey C.F., Qin S., Dayton P.A., Ferrara K.W. Microbubble tunneling in gel phantoms. J. Acoust. Soc. Am. 2009, 125:EL183-EL189.
77. Arvanitis C.D., Bazan-Peregrino M., Rifai B., Seymour L.W., Coussios C.C. Cavitation-enhanced extravasation for drug delivery. Ultrasound Med. Biol. 2011, 37:1838-1852.
78. Korpanty G., Chen S., Shohet R.V., Ding J., Yang B., Frenkel P.A., et al. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther. 2005, 12:1305-1312.
79. Tsunoda S., Mazda O., Oda Y., Iida Y., Akabame S., Kishida T., et al. Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem. Biophys. Res. Commun. 2005, 336:118-127.
80. Unger E.C., McCreery T.P., Sweitzer R.H., Caldwell V.E., Wu Y. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest. Radiol. 1998, 33:886-892.
81. Tartis M.S., McCallan J., Lum A.F., LaBell R., Stieger S.M., Matsunaga T.O., et al. Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med. Biol. 2006, 32:1771-1780.
82. Tinkov S., Coester C., Serba S., Geis N.A., Katus H.A., Winter G., et al. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. J. Control. Release Off. J. Control. Release Soc. 2010, 148:368-372.
83. de Wolf F.A., Maliepaard M., van Dorsten F., Berghuis I., Nicolay K., de Kruijff B. Comparable interaction of doxorubicin with various acidic phospholipids results in changes of lipid order and dynamics. Biochim. Biophys. Acta 1990, 1096:67-80.
84. Nicolay K., Sautereau A.M., Tocanne J.F., Brasseur R., Huart P., Ruysschaert J.M., et al. A comparative model membrane study on structural effects of membrane-active positively charged anti-tumor drugs. Biochim. Biophys. Acta 1988, 940:197-208.
85. Wu Y., Lu C., Li W., Sun C., Yang W., Zhang Y., et al. Preparation and antitumor activity of bFGF-mediated active targeting doxorubicin microbubbles. Drug Dev. Ind. Pharm. 2012, 1-8.
86. Zhao Y.Z., Sun C.Z., Lu C.T., Dai D.D., Lv H.F., Wu Y., et al. Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro. Cancer Lett. 2011, 311:187-194.
87. Terada T., Mizobata M., Kawakami S., Yamashita F., Hashida M. Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes. J. Control. Release Off. J. Control. Release Soc. 2007, 119:262-270.
88. Sirsi S.R., Fung C., Garg S., Tianning M.Y., Mountford P.A., Borden M.A. Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery. Theranostics. 2013, 3:409.
89. Perez-Gil J. Lipid-protein interactions of hydrophobic proteins SP-B and SP-C in lung surfactant assembly and dynamics. Pediatr. Pathol. Mol. Med. 2001, 20:445-469.
90. Bloch S.H., Wan M., Dayton P.A., Ferrara K.W. Optical observation of lipid- and polymer-shelled ultrasound microbubble contrast agents. Appl. Phys. Lett. 2004, 84:631.
91. Mehier-Humbert S., Yan F., Frinking P., Schneider M., Guy R.H., Bettinger T. Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjug. Chem. 2007, 18:652-662.
92. Eisenbrey J.R., Burstein O.M., Kambhampati R., Forsberg F., Liu J.B., Wheatley M.A. Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery. J. Control. Release Off. J. Control. Release Soc. 2010, 143:38-44.
93. Eisenbrey J.R., Soulen M.C., Wheatley M.A. Delivery of encapsulated doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents. IEEE Trans. Biomed. Eng. 2010, 57:24-28.
94. Cochran M.C., Eisenbrey J.R., Soulen M.C., Schultz S.M., Ouma R.O., White S.B., et al. Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model. Acad. Radiol. 2011, 18:1341-1348.
95. Dicker S., Mleczko M., Hensel K., Bartolomeo A., Schmitz G., Wrenn S. Coencapsulation of lipid microbubbles within polymer microcapsules for contrast applications. Bubble Sci Eng Technol. 2011, 3:12-19.
96. Kheirolomoom A., Dayton P.A., Lum A.F., Little E., Paoli E.E., Zheng H., et al. Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J. Control. Release Off. J. Control. Release Soc. 2007, 118:275-284.
97. Lentacker I., Geers B., Demeester J., De Smedt S.C., Sanders N.N. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol. Ther. J. Am. Soc. Gene Ther. 2010, 18:101-108.
98. Fan C.-H., Ting C.-Y., Lin H.-J., Wang C.-H., Liu H.-L., Yen T.-C., et al. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery. Biomaterials 2013, 34:3706-3715.
99. Niu C., Wang Z., Lu G., Krupka T.M., Sun Y., You Y., et al. Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes. Biomaterials 2013, 34:2307-2317.
100. Owen J., Pankhurst Q., Stride E. Magnetic targeting and ultrasound mediated drug delivery: benefits, limitations and combination. Int. J. Hyperth. Off. J. Eur. Soc. Hyperthermic Oncol. North Am. Hyperth. Group. 2012, 28:362-373.
101. Stride E., Porter C., Prieto A.G., Pankhurst Q. Enhancement of microbubble mediated gene delivery by simultaneous exposure to ultrasonic and magnetic fields. Ultrasound Med. Biol. 2009, 35:861-868.
102. Mulvana H., Eckersley R.J., Tang M.-X., Pankhurst Q., Stride E. Theoretical and experimental characterisation of magnetic microbubbles. Ultrasound Med. Biol. 2012, 38:864-875.
103. Owen J., Zhou B., Rademeyer P., Tang M.X., Pankhurst Q., Eckersley R., et al. Understanding the structure and mechanism of formation of a new magnetic microbubble formulation. Theranostics. 2012, 2:1127-1139.
104. Dove J.D., Murray T.W., Borden M.A. Enhanced photoacoustic response with plasmonic nanoparticle-templated microbubbles. Soft Matter 2013, 9:7743.
105. Leskinen J.T.T., Hakulinen M.A., Kuosmanen M., Ketolainen J., Abrahmsén-Alami S., Lappalainen R. Monitoring of swelling of hydrophilic polymer matrix tablets by ultrasound techniques. Int. J. Pharm. 2011, 404:142-147.
106. Lanting B., Barfett J. Encapsulated calcium carbonate suspensions: a drug delivery vehicle sensitive to ultrasound disruption. McGill J. Med. MJM Int. Forum Adv. Med. Sci. Stud. 2006, 9:108-110.
107. Bao M., Zhou Q., Dong W., Lou X., Zhang Y. Ultrasound-modulated shape memory and payload release effects in a biodegradable cylindrical rod made of chitosan-functionalized PLGA microspheres. Biomacromolecules 2013, 14:1971-1979.
108. Epstein-Barash H., Orbey G., Polat B.E., Ewoldt R.H., Feshitan J., Langer R., et al. A microcomposite hydrogel for repeated on-demand ultrasound-triggered drug delivery. Biomaterials 2010, 31:5208-5217.
109. Zhang M., Fabiilli M.L., Haworth K.J., Padilla F., Swanson S.D., Kripfgans O.D., et al. Acoustic droplet vaporization for enhancement of thermal ablation by high intensity focused ultrasound. Acad. Radiol. 2011, 18:1123-1132.
110. Zhu M., Jiang L., Fabiilli M.L., Zhang A., Fowlkes J.B., Xu L.X. Treatment of murine tumors using acoustic droplet vaporization-enhanced high intensity focused ultrasound. Phys. Med. Biol. 2013, 58:6179-6191.
111. Fabiilli M.L., Lee J.A., Kripfgans O.D., Carson P.L., Fowlkes J.B. Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions. Pharm. Res. 2010, 27:2753-2765.
112. Rapoport N. Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2012, 4:492-510.
113. Sheeran P.S., Dayton P.A. Phase-change contrast agents for imaging and therapy. Curr. Pharm. Des. 2012, 18:2152-2165.
114. Rapoport N., Gao Z., Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J. Natl. Cancer Inst. 2007, 99:1095-1106.
115. Gao Z., Kennedy A.M., Christensen D.A., Rapoport N.Y. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 2008, 48:260-270.
116. Rapoport N., Nam K.H., Gupta R., Gao Z., Mohan P., Payne A., et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J. Control. Release Off. J. Control. Release Soc. 2011, 153:4-15.
117. Kopechek J.A., Park E., Mei C.-S., McDannold N.J., Porter T.M. Accumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivo. J. Healthc. Eng. 2013, 4:109-126.
118. Couture O., Faivre M., Pannacci N., Babataheri A., Servois V., Tabeling P., et al. Ultrasound internal tattooing. Med. Phys. 2011, 38:1116-1123.
119. Phillips L.C., Puett C., Sheeran P.S., Dayton P.A., Miller G.W., Matsunaga T.O. Phase-shift perfluorocarbon agents enhance high intensity focused ultrasound thermal delivery with reduced near-field heating. J. Acoust. Soc. Am. 2013, 134:1473-1482.
120. Lin C.Y., Javadi M., Belnap D.M., Barrow J.R., Pitt W.G. Ultrasound sensitive eLiposomes containing doxorubicin for drug targeting therapy. Nanomedicine Nanotechnol. Biol. Med. 2013, 10(1):67-76.
121. Kagan D., Benchimol M.J., Claussen J.C., Chuluun-Erdene E., Esener S., Wang J. Acoustic droplet vaporization and propulsion of perfluorocarbon-loaded microbullets for targeted tissue penetration and deformation. Angew. Chem. Int. Ed. 2012, 51. (n/a-n/a).
122. Sheeran P.S., Luois S., Dayton P.A., Matsunaga T.O. Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound. Langmuir ACS J. Surf. Colloids. 2011, 27:10412-10420.
123. Sheeran P.S., Luois S.H., Mullin L.B., Matsunaga T.O., Dayton P.A. Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons. Biomaterials 2012, 33:3262-3269.
124. Chen H., Kreider W., Brayman A.A., Bailey M.R., Matula T.J. Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys. Rev. Lett. 2011, 106:034301.
125. Chen H., Brayman A.A., Evan A.P., Matula T.J. Preliminary observations on the spatial correlation between short-burst microbubble oscillations and vascular bioeffects. Ultrasound Med. Biol. 2012, 38:2151-2162.